# Protalix BioTherapeutics, Inc.: Form DEF 14A, filed May 18, 2023

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: DEF 14A
- Filed: 2023-05-18
- Accepted by EDGAR: May 18, 2023, 17:00 ET
- Period: 2023-06-28
- Accession: 0001104659-23-062301
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000110465923062301/tm232158-3_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000110465923062301/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000110465923062301/tm232158-3_def14a.htm

Filed May 18, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-062301. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
